UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly

NCT05565521 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme, Adult
Glioblastoma, IDH-mutant

Interventions

RADIATION: Dose escalation + Reduced Margin Adaptive Radiotherapy

Sponsor

Sunnybrook Health Sciences Centre